Smokers' Health Project: Self-Determination and Maintaining Tobacco Abstinence

NCT00178685 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 837

Last updated 2013-02-15

Study results available
· View outcomes & findings →

Summary

These two studies will examine the role of autonomous motivation in maintained adherence. The first study will determine whether smokers are still abstinent from tobacco 32 months after starting in a previous project (Smoker's Health Study). The purpose of the second study is to determine which of three treatments for tobacco dependence provides the greatest amount of protection from relapsing to smoking after quitting. Specifically, the investigators will determine if extending the length of treatment time focusing on relapse prevention and arranging for support from important others prevents relapse compared to community care. Also, the investigators will determine if providing extended treatment time and support from important others plus providing medications to those that don't want to quit prevents long term relapse compared to just extending the length of treatment time and support from others. Additionally, a sub set of the population will be randomized to using hand held palm devices to recover real-time data assessment during the last 10 months of the project.

Conditions

  • Tobacco Use Disorder

Interventions

BEHAVIORAL

Self-determination Intervention for Tobacco Dependence

autonomy supported behavioral intervention for tobacco dependent individuals

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH
  • New York State Department of Health

    collaborator OTHER_GOV
  • Greater Rochester Area Tobacco Cessation Center

    collaborator UNKNOWN
  • Health Maintenance Consortium

    collaborator UNKNOWN
  • National Institutes of Health (NIH)

    collaborator NIH
  • University of Rochester

    lead OTHER

Principal Investigators

  • Geoffrey C Williams, MD, Ph.D. · University of Rochester

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-08-31
Primary Completion
2008-08-31
Completion
2008-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00178685 on ClinicalTrials.gov